At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.
Ganzel C, Wang XV, Rowe JM, Richards SM, Buck G, Marks DI, Litzow MR, Paietta EM, Foroni L, Luger SM, Willman CL, Mullighan CG, Roberts KG, Wiernik PH, Douer D, Lazarus HM, Tallman MS, Goldstone AH.
Ganzel C, et al. Among authors: foroni l.
Br J Haematol. 2020 Oct;191(1):37-43. doi: 10.1111/bjh.16616. Epub 2020 Mar 27.
Br J Haematol. 2020.
PMID: 32220069
Free PMC article.
Clinical Trial.